Transport And Storage of The Corona Vaccine from The Manufacturers BioNTech And Pfizer Now Much Easier
The European Medicines Agency (EMA) has made the conditions for transport and storage of the corona vaccine from the manufacturers BioNTech and Pfizer much easier. The EMA announced on Friday in Amsterdam that the preparation could also be stored for short periods in standard refrigeration units for medicines. Previously, the vaccine had to be stored in special freezers at temperatures down to minus 90 degrees. Therefore vaccination was only possible in large centers. Now the EMA also allows …
The European Medicines Agency (EMA) has officially approved two production sites for corona vaccines in Germany and the Netherlands. The plant in Marburg produces the vaccine from Pfizer / Biontech. The Halix company in Leiden, the Netherlands, manufactures Astrazeneca’s product.
With the decision, bottlenecks in the supply of the Astrazeneca vaccine could be eased in the short term, as the pre-produced vaccine doses could be delivered quickly. Both companies have already produced, but were not allowed to deliver without EMA approval. It is not known how large the supplies are.
EU Health Commissioner Stella Kyriakides welcomed the approval and hopes that at least part of the backlogs from Astrazeneca can be made good. “We now expect the vaccines that are manufactured in this plant to be shipped to the EU member states in the next few days, as part of the contractual commitment and commitments made by Astrazeneca to the citizens of Europe,” said the Commissioner in Brussels. Some EU states are severely affected by the “disappointing delivery cuts” by the British-Swedish manufacturer.
The company had repeatedly cut its pledges and promised 30 million cans by March 30, but only 17 million were shipped. It is unclear, however, whether the vaccination doses produced by Halix will also be delivered to the EU or whether they are intended for the UK. The EU controls vaccine exports and can prohibit them if necessary. Halix has been producing the vaccine for weeks, but recently applied to the EMA for EU approval.
So far, only one plant in Belgium was officially approved for the production of Astrazenca in the EU. The vaccine is also made in the US and the UK. With the approval of the Marburg plant, the production of the Pfizer / Biontech active ingredient can also be increased.
The EMA has also made the conditions for the transport and storage of the corona vaccine from the manufacturers Pfizer and Biontech considerably easier. The EMA announced that the preparation could also be stored in standard refrigeration for pharmaceuticals for a short time.
Until now, the vaccine had to be stored in special freezers at temperatures down to minus 90 degrees. Therefore vaccination was only possible in large centers. The EMA now allows the ampoules to be transported and stored at temperatures of minus 25 to minus 15 degrees – for a period of up to two weeks. Standard refrigeration for drugs is sufficient for this.